Correlation Between Oryzon Genomics and Holaluz Clidom

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oryzon Genomics and Holaluz Clidom at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oryzon Genomics and Holaluz Clidom into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oryzon Genomics SA and Holaluz Clidom SA, you can compare the effects of market volatilities on Oryzon Genomics and Holaluz Clidom and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oryzon Genomics with a short position of Holaluz Clidom. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oryzon Genomics and Holaluz Clidom.

Diversification Opportunities for Oryzon Genomics and Holaluz Clidom

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Oryzon and Holaluz is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Oryzon Genomics SA and Holaluz Clidom SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Holaluz Clidom SA and Oryzon Genomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oryzon Genomics SA are associated (or correlated) with Holaluz Clidom. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Holaluz Clidom SA has no effect on the direction of Oryzon Genomics i.e., Oryzon Genomics and Holaluz Clidom go up and down completely randomly.

Pair Corralation between Oryzon Genomics and Holaluz Clidom

Assuming the 90 days trading horizon Oryzon Genomics SA is expected to generate 0.44 times more return on investment than Holaluz Clidom. However, Oryzon Genomics SA is 2.26 times less risky than Holaluz Clidom. It trades about -0.05 of its potential returns per unit of risk. Holaluz Clidom SA is currently generating about -0.08 per unit of risk. If you would invest  155.00  in Oryzon Genomics SA on October 7, 2024 and sell it today you would lose (5.00) from holding Oryzon Genomics SA or give up 3.23% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Oryzon Genomics SA  vs.  Holaluz Clidom SA

 Performance 
       Timeline  
Oryzon Genomics SA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oryzon Genomics SA has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Holaluz Clidom SA 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Holaluz Clidom SA are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady basic indicators, Holaluz Clidom may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Oryzon Genomics and Holaluz Clidom Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oryzon Genomics and Holaluz Clidom

The main advantage of trading using opposite Oryzon Genomics and Holaluz Clidom positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oryzon Genomics position performs unexpectedly, Holaluz Clidom can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Holaluz Clidom will offset losses from the drop in Holaluz Clidom's long position.
The idea behind Oryzon Genomics SA and Holaluz Clidom SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories